As we navigate the unprecedented challenges facing academic medicine and the U.S. health care system — funding uncertainty, threats to insurance coverage and more — it’s easy to feel discouraged. […]
LEAP Winter 2026: Partnering to Advance Therapy
LEAP Winter 2025: Fighting Fire with Fire
In the Division of Rheumatology, we have a deeply ingrained philosophy that our patients are at the center of all we do — that their clinical and life experiences help […]
LEAP Winter 2024: At the Cusp of Breakthroughs
At the Cusp of Breakthroughs,” “Game Changer,” “At Last, an Answer.” As you can tell from our headlines, so much is happening here in the Division of Rheumatology. If we […]
LEAP – Winter 2023: Big Data, Individualized Care
In Rheumatology, we have more bits of information about our patients with chronic diseases than we can manage, without help. Just one visit, for example, generates results of tests and […]
LEAP Rounds – Winter 2023
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of many cancers, enabling long-term remission and potentially curative responses. But there’s a downside: these drugs also can result in inflammatory syndromes […]
LEAP Rounds – Fall 2023
Never underestimate the body’s ability to compensate. We have seen this in our patients with inclusion body myositis (IBM), thanks in part to musculoskeletal ultrasound, as part of a recent […]
